Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II neoadjuvant GAS chemotherapy for locally advanced pancreatic cancer
jRCTs061180045Phase 2Completed
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel, gemcitabine and tegafur in pancreatic cancer (PC). Primary endpoints: Incidence of adverse events meeting discontinuation criteria, Two-year survival rate and 1 more. Started Mar 2015; status: completed.
02
Drugs
paclitaxelgemcitabinetegafur
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on jRCTs061180045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061180045.